Playback speed
10 seconds
SGO 2024 Insights: "Final OS Data of Relacorilant, a Selective Glucocorticoid Receptor Modulator, in Combination With Nab-Paclitaxel in Pts With Recurrent Platinum-Resistant Ovarian Cancer"
By
Insights from 2024 SGO Annual Meeting
FEATURING
Nicoletta Colombo
By
Insights from 2024 SGO Annual Meeting
FEATURING
Nicoletta Colombo
256 views
March 26, 2024
Comments 0
Login to view comments.
Click here to Login